Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21748)

• Formulation Name: Ursodeoxycholic acid 250 mg tablet
• Company: Allergan

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ursodeoxycholic acid	(DMCUT21)	Cholelithiasis	DC11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Dibutyl sebacate	(E00160)	7986	Plasticizing agent
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant